NCT07117942View on ClinicalTrials.gov

FDGL Dose-Finding Study for Diabetic Neuropathy

PHASE2CompletedINTERVENTIONAL
Enrollment

485

Participants

Timeline

Start Date

February 12, 2020

Primary Completion Date

June 18, 2021

Study Completion Date

April 10, 2023

Conditions
Diabetic Neuropathy
Interventions
DRUG

Fermented Deglycyrrhizinated Licorice (FDGL)

Fermented Deglycyrrhizinated Licorice (FDGL) in oral powder capsules; prepared through three consecutive steps: fermentation of licorice roots, removal of glycyrrhizinic acid content (deglycyrrhizination), and lyophilization according to EUROPEAN PATENT SPECIFICATION Ep 1 925 312 B

Trial Locations (1)

11651

Al-Azhar University, Cairo

All Listed Sponsors
lead

Helwan University

OTHER

NCT07117942 - FDGL Dose-Finding Study for Diabetic Neuropathy | Biotech Hunter | Biotech Hunter